| HANNA PHARMA LTD |
| Notes to the Accounts |
| for the year ended 31 August 2025 |
|
|
| 1 |
Accounting policies |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Computer equiptment |
20% |
|
|
| 1a |
Compliance with accounting standards |
|
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard. material departures from that standard. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
2 |
|
2 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
|
|
|
|
Computer equiptment |
| £ |
|
Cost |
|
At 1 September 2024 |
3,300 |
|
Additions |
6,828 |
|
At 31 August 2025 |
10,128 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 September 2024 |
2,434 |
|
Charge for the year |
1,540 |
|
At 31 August 2025 |
3,974 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 August 2025 |
6,154 |
|
At 31 August 2024 |
866 |
|
|
| 4 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
6,050 |
|
10,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Accruals |
1,395 |
|
1,375 |
|
Corporation tax |
9,655 |
|
8,755 |
|
Director's loans |
345 |
|
391 |
|
|
|
|
|
|
11,395 |
|
10,521 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Other information |
|
|
HANNA PHARMA LTD is a private company limited by shares and incorporated in England. Its registered office is: |
|
7 Lindhurst Way West |
|
Mansfield |
|
NG18 6AP |